72
Overbought
Moving averages
SMA 200$45.92+216.05%
Company profile
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$24.18B
P/E ratioNone
EPS$-7.98
Beta0.899
Dividend yield0.00%
52-week high$85.60
52-week low$22.28
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 79
VRTX
Vertex Pharmaceuticals Inc
RSI 67
CRSP
CRISPR Therapeutics AG
RSI 67
IOVA
Iovance Biotherapeutics Inc
RSI 72
VKTX
Viking Therapeutics Inc
RSI 48
SRPT
Sarepta Therapeutics Inc
RSI 59
EDIT
Editas Medicine Inc
RSI 57
NVAX
Novavax Inc
RSI 63
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 46
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 59
RSI alerts for MRNA
Get an email the moment Moderna Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 12 August 2026 at 7:34 AM EDT